News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilent Technologies Inc. (A) , Human Metabolome Technologies To Co-develop Metabolomics Solution For Disease And Drug Research



10/19/2005 5:09:19 PM

Tokyo (JCNN) - On June 20, Agilent Technologies and Human Metabolome Technologies (HMT) announced that they have reached an agreement to collaborate in developing an integrated solution for metabolome analysis. Under the terms of the agreement, the two companies will combine HMT's biochemical assays with Agilent's capillary electrophoresis (CE) and mass spectrometry (MS) technologies, and develop a new solution that will be able to profile, identify and determine the quantity of metabolic markers.

Read at JCN Newswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES